Clinical Trials Browser

Parkinson Disease 4, Autosomal Dominant Lewy Body, Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Mouth Neoplasms, Neoplasm Metastasis, Neoplasms, Oropharyngeal Neoplasms, Recurrence

NCT07022002 2025-08-03

SSGJ-705 Monotherapy and Combination Therapy in Advanced HER2-Expressing Solid Tumors

Phase 2 Recruiting

340 enrolled

Neoplasms, Recurrence

NCT06670911 2025-02-24

ACCESS-I

Phase 2 Recruiting

44 enrolled

Recurrence

NCT06750952 2024-12-27

iTHYM

Phase 2 Not yet recruiting

24 enrolled

Recurrence, Thymus Neoplasms

NCT05512182 2023-06-15

Efficacy of Triplet Combination With Pembrolizumab, Neratinib, and Paclitaxel as a Second Line Treatment in Recurrent/Advanced Gastric Cancer Having Somatic Human Epidermal Growth Factor Receptor Family (EGFR, HER2, HER3, HER4) Mutations or HER2 Amplification/Overexpression

Phase 2 Withdrawn

Recurrence

NCT01809379 2022-07-08

Intraperitoneal Aerosol High-pressure Chemotherapy for Women With Recurrent Ovarian Cancer

Phase 2 Completed

69 enrolled

Gynecologic

Ovarian Neoplasms, Recurrence

NCT03297528 2020-03-10

Chemotherapy and DLI for Prevention of Second Relapse in Patients With Relapsed Acute Leukemia After Allotransplant

Phase 2 Unknown

40 enrolled

Graft vs Host Disease, Recurrence, Neoplasm, Residual

NCT02410187 2016-03-03

SBRT for Extra-cranial Oligorecurrent Tumor

Phase 2 Unknown

1 enrolled

Recurrence

NCT00005969 2012-02-20

Liposomal Tretinoin in Treating Patients With Recurrent or Refractory Hodgkin's Disease

Phase 2 Withdrawn

Lymphoid

Hodgkin Disease, Lymphoma, Recurrence

Clinical Trials

Chemoradiation vs Immunotherapy and Radiation for Head and Neck Cancer

SSGJ-705 Monotherapy and Combination Therapy in Advanced HER2-Expressing Solid Tumors

ACCESS-I

iTHYM

Efficacy of Triplet Combination With Pembrolizumab, Neratinib, and Paclitaxel as a Second Line Treatment in Recurrent/Advanced Gastric Cancer Having Somatic Human Epidermal Growth Factor Receptor Family (EGFR, HER2, HER3, HER4) Mutations or HER2 Amplification/Overexpression

Intraperitoneal Aerosol High-pressure Chemotherapy for Women With Recurrent Ovarian Cancer

Chemotherapy and DLI for Prevention of Second Relapse in Patients With Relapsed Acute Leukemia After Allotransplant

SBRT for Extra-cranial Oligorecurrent Tumor

Liposomal Tretinoin in Treating Patients With Recurrent or Refractory Hodgkin's Disease